# Adaptimmune Therapeutics PLC: Form SC 13D/A, filed Apr 2, 2024

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: SC 13D/A
- Filed: 2024-04-02
- Accepted by EDGAR: Apr 2, 2024, 20:38 ET
- Period: not reported
- Accession: 0001072613-24-000360
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000107261324000360/nea14-adaptimmune_18818.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000107261324000360/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000107261324000360/nea14-adaptimmune_18818.htm

Filed Apr 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001072613-24-000360. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.